🇺🇸 FDA
Patent

US 10449171

Compositions and methods for diagnosis and treatment of metabolic syndrome

granted A61KA61K31/20

Quick answer

US patent 10449171 (Compositions and methods for diagnosis and treatment of metabolic syndrome) held by The United States of America, as represented by Secretary of the Navy expires Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by Secretary of the Navy
Grant date
Tue Oct 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/20